A Dual Energy Catheter (PFA and RFA) and a PFA Catheter for the Treatment of PeAF

Exclusion Criteria

• •1. Patients who have undergone left atrial surgery
• •2. Left atrial thrombosis
• •3. Patients with combined atrial tachycardia and atypical atrial flutter
• •4. Patients of childbearing age who are unable to use effective contraception during the 3-month period following enrollment
• •5. Anterior and posterior left atrial diameter ≥ 55mm
• •6. Left ventricular ejection fraction (LVEF) ≤ 40%
• •7. Previous atrial septal repair or atrial mucinous tumor
• •8. Active implants (e.g. pacemakers, ICDs, etc.) in the body
• •9. NYHA class III-IV cardiac function
• •10. Clear cerebrovascular disease within the last 6 months (including cerebral hemorrhage, stroke, transient ischemic attack)
• •11. Cardiovascular events within the last 3 months (including acute myocardial infarction, coronary intervention or heart bypass surgery, prosthetic valve replacement or repair, atrial or ventriculotomy)
• •12. Those with acute or severe systemic infections
• •13. Patients with severe liver or kidney disease, malignant tumors or end-stage disease that, in the opinion of the investigator, may interfere with the treatment, evaluation and compliance of this trial
• •14. Patients with significant bleeding tendency, hypercoagulable state and severe hematologic disorders
• •15. Patients who have participated or are participating in other clinical trials within 3 months prior to enrollment
• •16. Patients who have other conditions that the investigator considers inappropriate for participation in this trial.